On May 24, 2023 (NASDAQ: PULM), a clinical-stage biopharmaceutical company developing innovative inhaled therapies to address serious pulmonary and central nervous system disease using its patented iSPERSE technology, reported that management will present at the annual Biotechnology Innovation Organization (BIO) International Convention, to be held in-person in Boston, MA, June 5 – 8, 2023 (Press release, Pulmatrix, MAY 24, 2023, View Source [SID1234632005]). Presentation details are below. Pulmatrix management will also be available for one-on-one meetings throughout the conference.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

BIO International Convention Presentation Information:

Format: Live presentation
Presenter: Ted Raad, Chief Executive Officer, Pulmatrix, Inc.
Date: Monday, June 5, 2023
Time: 12:45 PM EDT
Location: Room 104A

Following the live presentation at BIO on June 5th, the presentation will be posted on Pulmatrix’s website.